Sees FY26 system-wide comparable RevPAR, on a currency neutral basis, up 1.0%-2.0% vs. last year; adjusted EBITDA $4.000B-$4.040B; contract acquisition costs and capital expenditures, excluding amounts reimbursed by third parties, are projected to be approximately $300M; net unit growth 6.0%-7.0%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLT: